Nyra Medical is developing a first-in-class transcatheter heart valve repair technology
Nyra Medical has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Nyra Medical's investors include Epidarex Capital, Vensana Capital, Broadview Ventures, Georgia Research Alliance, MedTech Innovator.
Nyra Medical is headquartered in Atlanta, United States.
Nyra Medical is developing a first-in-class transcatheter heart valve repair technology
Nyra Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nyra Medical — Funding & Investors." VCBacked, November 18, 2022, https://www.vcbacked.co/company/nyra-medical. Accessed July 23, 2026.
VCBacked. (2022). Nyra Medical — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/nyra-medical
{{cite web |title=Nyra Medical — Funding & Investors |url=https://www.vcbacked.co/company/nyra-medical |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated